phl 63

IRISH RUGBY PLAYER Denis Coulson has been sentenced to 14 years in prison after he was found guilty of the 2017 gang rape of a student in France. Coulson and Loick Jammes of France were both jailed for 14 years by a French court on Friday, while Rory Grice of New Zealand was given a 12-year sentence. Former Ireland international Chris Farrell was sentenced to four years, with two suspended, for his failure to prevent the crime. RTÉ reports that Farrell will not serve time in prison but will be required to wear an electronic tag for two years and remain in France. Dylan Hayes of New Zealand received a two-year suspended sentence, also for not intervening to prevent the crime. All five were team-mates at Grenoble Rugby at the time of the crime in the early hours of 12 March 2017, when a student, identified only as ‘V’, filed a complaint to police. She alleged that the sexual attack happened in a hotel on the outskirts of Bordeaux having met members of the Grenoble team as they socialised after losing a Top 14 encounter against local side Bordeaux-Begles. V filed a complaint with police, saying she had met the players in a bar together with two friends and accompanied them to a nightclub where all of them drank heavily. The student said she had no recollection of how she got from the club to the hotel where she woke up, naked on a bed and with a crutch inserted in her vagina. She saw two naked men in the room and others fully dressed. Coulson, Jammes and Grice stated they had sexual relations with V but claimed the encounter was consensual and the student had been pro-active in bringing it about. It was alleged that Farrell, owner of the crutch, was present, as was Hayes. Evidence in the Bordeaux trial was heard without media in the court. The victim’s lawyer Anne Cadiot-Feidt said it had been “unbearable” during the trial to hear the defendants describe her client as “a trollop – if I’m being polite – an eager party who used them and even exhausted them”. “It’s vile, it’s disgusting, it’s obscene and that is perhaps also why the sentencing requests are what they are,” she said. Gaessy Gros, another lawyer for the victim, said those accused had “missed their chance” by continuing to deny rape and remaining united like a team on the rugby pitch. Valerie Coriatt, defending Grice, however described the requested sentences as “almost indecent” for defendants who, she said, “are not a danger to society”. On the basis of statements from the accused and witnesses, as well as a video shot by Coulson, investigators have concluded there were several incidents where objects, including the crutch, a banana and a bottle, were inserted in V’s vagina. A toxicology report stated her blood alcohol level was between 2.2 and 3 grams, a level considered in the danger zone for alcohol poisoning. CCTV footage showed her having difficulty standing up as she arrived at the hotel and being propped up by a player. In court this week, Gros stressed that the victim had no recollection of what happened after leaving the night club. A psychiatric expert said she would likely have been on “automatic pilot” during the alleged rape. Gros has said V was “in no state to give her consent as these men who carried her, who were with her, know perfectly well.” Coulson’s lawyer, Corinne Dreyfus-Schmidt, earlier this week described the victim as “very active” and willing. “If you see someone who is completely lifeless, in an alcohol coma, and you sexually abuse her, it’s not the same thing as if you see a woman who is taking action, moaning and acting in a coordinated way. That’s what they saw,” she said. On Wednesday, she said her client had apologised to the victim. “He asked her for forgiveness and he asked his teammates too because he feels responsible in as much as it was him who led the young woman into the room,” she said. Denis Dreyfus, defending Jammes, said there was not “the slightest ambiguity” on the plaintiff’s attitude. Arnaud Lucien, representing Hayes, said the jail terms requested were “very high”, saying there had not been enough of a distinction between the behaviour of each person in the case.FuelCell Energy Inc. stock falls Monday, underperforms marketphl 63 。

CHECK OUT: Education is Your Right! Don’t Let Social Norms Hold You Back. Learn Online with LEGIT. Enroll Now! Legit.ng journalist Adekunle Dada has over 7 years of experience covering metro, government policy, and international events Ikeja, Lagos state - A suspected online fraudster, Osang Usie Otukpa, has been arrested for allegedly duping 139 Australians to the tune of $AUD8,000,000 (Eight Million Australian Dollars). The Economic and Financial Crimes Commission (EFCC) operatives arrested Otukpa upon arrival from the United States at the Murtala Mohammed International Airport, Ikeja, Lagos on Friday, December 6, 2024. Otukpa scammed the victims by luring them on social media to invest in his rogue cryptocurrency investment platform, Liquid Asset Group, LAG. PAY ATTENTION: Follow us on Instagram - get the most important news directly in your favourite app! This was disclosed in a statement issued via the EFCC X handle (formerly known as Twitter) @officialEFCC on Friday, December 13. The anti-graft agency said the suspect goes by five aliases, namely: Ford Thompson, Oscar Donald Tyler, Michael Haye, Jose Vitto, and Kristin Davidson EFCC disclosed that the proceeds of the alleged crimes were routed to his bank accounts through a global cryptocurrency exchange platform. Read also Nigerian army explains strategy that made 129,417 terrorists surrender in 6 months The commission said the suspect would be charged to court upon conclusion of investigations. Court Sentences Internet Fraudster to One Year imprisonment Meanwhile, Legit,ng reported that Praise Humphrey Igbo, using the alias Jessica Allen, impersonated a U.S.-based cryptocurrency trader and defrauded Aaron Baker of $115,000 in Bitcoin . The EFCC prosecuted Igbo, leading to his conviction and a one-year prison sentence, with an alternative fine of one million Naira . The court ordered the restitution of recovered assets, including $16,110 in cash and $67,487.79 worth of cryptocurrency, to the victim through the American Embassy. PAY ATTENTION: Сheck out news that is picked exactly for YOU ➡️ find the “Recommended for you” block on the home page and enjoy! Source: Legit.ng

Lithium Argentina Files Meeting Materials to Establish Corporate Domicile in SwitzerlandStock market today: Nasdaq tops 20,000 for first time as Big Tech surges, Tesla hits first record in 3 years

Washington Commanders wide receiver Noah Brown could miss the rest of the season with an internal injury, coach Dan Quinn confirmed Wednesday. Initial reports said Brown had sustained a rib injury in Washington's 42-19 win against the Tennessee Titans on Dec. 1. Quinn updated Brown's status as the Commanders (8-5) return from their bye week and prepare to visit the New Orleans Saints (5-8) on Sunday. "He's going to be out for a while," Quinn said. "He had a significant internal injury from the game, so that's going to knock him out for a while." Brown, 28, did not practice on Wednesday because of a kidney injury, according to the team's injury report. He caught three passes for 27 yards against the Titans before leaving late in the third quarter. "During the game, between him and the medical staff, they did a really good job to address what was a serious injury," Quinn said. "Fortunately, he's going to be OK. But it's going to knock him out for a bit." Quinn said it's not certain Brown will miss the rest of the season "but it's likely heading that way." The Commanders claimed veteran wide receiver K.J. Osborn off waivers from New England on Wednesday afternoon. The Patriots released Osborn on Tuesday. Osborn, 27, played in seven games (four starts) and had seven receptions on 18 targets for 57 yards and one touchdown. He participated in 53 percent (232) of the offensive snaps. He has not played since the Patriots' 19-3 victory at Chicago on Nov. 10. The Patriots signed Osborn as a free agent in March after he spent four seasons with the Minnesota Vikings, who selected him in the fifth round of the 2020 NFL Draft. Osborn has 165 career receptions for 1,902 yards and 16 TDs in 66 regular-season games (34 starts). Brown ranks third on the team in receptions (35) and receiving yards (453) and has one touchdown in 11 games (nine starts). His touchdown catch was on a 52-yard Hail Mary pass that gave Washington an 18-15 win over the Chicago Bears in Week 8. A seventh-round draft pick by Dallas in 2017, Brown has 150 catches for 2,000 yards and six TDs in 87 games (34 starts) with the Cowboys (2017-18, 2020-22), Houston Texans (2023) and Commanders. --Field Level Media

Will Canada’s primary stock market outperform in 2025? According to the 13th annual forecast of strategists, the TSX will do better than its U.S. counterparts next year. “We think Canada offers value and cyclicality and increase in stock picking, especially relative to the U.S.,” said Brian Belski, BMO’s chief investment strategist. But what should Canadian investors pick in preparation and include in their shopping lists this month? Belski is bullish about . He thinks they can do very well over the next decade. As of this writing, the technology sector is the top performer among 11 primary sectors thus far in 2024. Only the communications services sector is losing. is up 11.41% year to date, although two stocks in the Oil & Gas, Equipment & Services industry stand out. If you have $1,000 to invest right now, ( ) and ( ) are no-brainer options. You can even take positions in both, as the companies have different areas of expertise. CES Energy Solutions provides molecular-level chemical solutions to clients in Canada and the United States. The $2.16 billion company generates free cash flow (FCF) from a low-capital intensity, vertically integrated consumables business model. At $9.49 per share, current investors enjoy a 179.13% year-to-date gain on top of a modest 1.27% dividend yield (quarterly payout). The financial performance in the third quarter (Q3) of 2024 shows in the stock’s performance. Also, CEU is a 2024 TSX30 winner. It ranked fourth in the flagship program for Canada’s top growth stocks. In Q3 2024, revenue increased 13% year over year to record $606.5 million versus Q3 2023. Net income climbed 21% to $46.6 million from a year ago. Both core markets, Canada ($203.9 million) and the U.S. ($402.6 million), set new quarterly revenue records. Management expects increased service intensity and enhanced drilling activities because of global demand requirements and demand trends of developing countries. CEU Energy maintains a positive outlook despite economic uncertainty and global conflicts. Strong energy industry fundamentals will continue supporting critical oil and natural gas drilling and production activity. Enerflex provides vertically integrated and comprehensive energy infrastructure solutions to customers in North America, Latin America, and the Eastern Hemisphere. If you invest today, the share price is $13.61 (+124.87% year to date), while the divided offer is 1.33%. This $1.67 billion energy services company engages in gas treatment, processing, compression, refrigeration, and electric power. The infrastructure segment offers build-own-operate-maintain solutions, water treatment solutions, and integrated turnkey. In Q3 2024, revenue increased 3.6% to $601 million compared to Q3 2023, a new record for Enerflex. Operating income and net earnings rose 137.5% and 650% year over year to $57 million and $30 million, respectively. The $1.3 billion engineered services backlog indicates visible revenue growth. Preet Dhindsa, Enerflex’s senior vice president and chief financial officer, said the near-term plan is to deploy selective growth capital to customer-supported opportunities in the U.S. and Middle East that can generate attractive returns and deliver shareholder value. CEU Energy Solutions and Enerflex have strong, unstoppable upward momentum heading into 2025. Canadians with limited investment budgets or who have $1,000 to spare can earn two ways: price appreciation and dividends.

Trump’s lawyers rebuff DA’s idea for upholding his hush money conviction, calling it ‘absurd’SAN FRANCISO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FemPulseTM announced today Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin its EVANESCE II pivotal clinical trial in female patients suffering from overactive bladder (OAB). OAB is the first application of FemPulse's patented female health platform. Peter Fredericks, Chairman, said, "We want to thank everyone at FDA for their thorough review and clear dedication to patient safety. This is an important milestone towards serving the 1 in 6 women worldwide suffering with OAB." Alexandra Haessler, MD, founder and Chief Medical Officer, commented, "I created the vaginally-inserted and removable FemPulse RingTM as an ‘internal wearable' to provide continuous OAB neuromodulation therapy without requiring surgery. The wearable ring is discreet and patient-managed with a ‘set it and forget it' approach. Medications can have limited efficacy and intolerable side-effects, so patients discontinue them up to 80% of the time. The trial is randomized against medication to confirm the FemPulse Ring as a first-line alternative to medications. Implanted sacral neuromodulation therapy is effective but invasive, and access to surgical implantation is limited, especially outside the U.S. In 25 years as the ‘gold standard' treatment, less than 1% of OAB sufferers have been treated with this approach. We look forward to increasing access to neuromodulation therapy for the millions of women suffering from OAB." Suzette Sutherland, MD, who served as the Principal Investigator (PI) on two previous successful clinical trials of the FemPulse Ring while Director of Female Urology at the University of Washington, commented, "My hands-on experience using the FemPulse Ring with patients and the clinical trial results confirmed my strong belief in FemPulse's wearable therapy. I am thrilled to support FemPulse in this multi-center IDE trial and look forward to once again sharing the results at international conferences." The FemPulse SystemTM has advanced to the final stage of the new Medical Device Regulation (MDR) process for commercial clearance in the European Union (EU), with the Technical File submitted. Dr. Haessler said, "It is exciting that our FemPulse Ring may be commercially available in the EU in 2025. We certainly hope to serve as many OAB patients in the EU as in the U.S." About FemPulse FemPulse Corporation is a bioelectronic medicine company developing a novel wearable bioelectronic platform for the personalized treatment of medical conditions in women. FemPulse's vaginally-inserted, wearable neuromodulation device is intended to provide mild electrical nerve stimulation as a first-line alternative to pharmaceutical medications. The initial application is to treat the one in six women worldwide suffering from overactive bladder (OAB). For more information, visit www.fempulse.com . Forward-Looking Statements All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the effectiveness of the Company's technology, future clinical studies, future regulatory submissions, and potential regulatory approvals. Actual results may differ materially from those in the forward-looking statements. FemPulse undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future. Investor Contact: Peter Fredericks Chairman, FemPulse 415-577-5441 pfredericks@fempulse.com FemPulse, The Elegant Solution, FemPulse System, and FemPulse Ring are trademarks of FemPulse. ©2024 FemPulse. All Rights Reserved. CAUTION: The FemPulse System is for investigational use only. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.